Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007
Medication labelWhy this: Advisory · dailymed-prescription
COMBIGAN® is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of COMBIGAN dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day.
- generic_name
- brimonidine tartrate, timolol maleate
- product_names
- brimonidine tartrate, timolol maleate
- ndc
- 0023-9211, 0023-9211-03, 0023-9211-05, 0023-9211-10, 0023-9211-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en